ArticleJournal of clinical immunology2026
Tofacitinib as a Successful Treatment for Hyper-IgE Syndrome and Autoimmunity Associated with Constitutive Activation of JAK3.
Yuxin Pei et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.